Sen. Chuck Schumer, the Senate minority leader, accused Health and Human Services Secretary Robert F. Kennedy Jr. of gutting ...

The FDA this week fully approved Moderna’s COVID-19 vaccine for children aged 6 months to 11 years but limited the approval ...

According to Pfizer, "Hundreds of millions of doses of the Pfizer-BioNTech COVID-19 vaccine have been administered globally, ...

Novavax's growth relies on Sanofi royalties and COVID/flu vaccines, lacking innovation and clear catalysts. Click here to ...

The U.S. Food and Drug Administration approved "Spikevax," Moderna's vaccine for children aged 6 months to 11 years old. The ...

The Food and Drug Administration July 10 approved Moderna’s Spikevax COVID-19 vaccine for children under 12 with at least one ...

Kennedy selected a new team of medical professionals and scientists who are looking at vaccines are highly qualified.

Symptoms mirror Omicron’s, that is, fever, cough, fatigue, sore throat, and muscle aches. Though India’s Covid response ...

A Qatar-based study involving 121,700 patients has underscored the importance of the post-vaccination monitoring to optimise ...

Titer tests are what's used "to help you determine if you currently have immunity to certain diseases due to past infection or vaccination,” says Dr. Alison Mitzner, a New York board-certified ...

The company expects to make the updated Spikevax available to U.S. patients in time for the 2025-26 respiratory virus season.

Scientists say the current COVID vaccine is effective against the Nimbus variant and is considered a “variant under ...